Eyenovia to end eye drug study, cut 50% of its workforce
![](https://americanfinanceinsider.com/wp-content/uploads/2024/11/LYNXMPEKAE0O6_L-bEuWj8.jpeg)
(Reuters) -Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce. Shares of the company…